Published in Lancet Neurol on June 01, 2006
Incidence of sudden unexpected death in nocturnal frontal lobe epilepsy: a cohort study. Sleep Med (2014) 2.00
A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance. Epilepsia (2009) 1.07
Heart rate variability in normal and pathological sleep. Front Physiol (2013) 1.03
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307. Epilepsia (2014) 0.93
Sudden unexpected death in epilepsy (SUDEP): a pilot study on truth telling among Italian epileptologists. Neurol Sci (2010) 0.88
Managing drug-resistant epilepsy: challenges and solutions. Neuropsychiatr Dis Treat (2016) 0.85
Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study. Eur J Epidemiol (2013) 0.80
Heart rate changes in partial seizures: analysis of influencing factors among refractory patients. BMC Neurol (2014) 0.80
Epilepsy, excess deaths and years of life lost from external causes. Eur J Epidemiol (2015) 0.79
Premature mortality in poor health and low income adults with epilepsy. Epilepsia (2014) 0.78
Functional network alterations and their structural substrate in drug-resistant epilepsy. Front Neurosci (2014) 0.77
Seizing Control: From Current Treatments to Optogenetic Interventions in Epilepsy. Neuroscientist (2015) 0.77
Cause-specific mortality in adult epilepsy patients from Tyrol, Austria: hospital-based study. J Neurol (2014) 0.76
Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review. Obstet Med (2014) 0.75
Etiology of Sudden Cardiac Arrest in Patients with Epilepsy: Experience of Tertiary Referral Hospital in Sapporo City, Japan. Neurol Med Chir (Tokyo) (2016) 0.75
Electrocardiographic changes in patients with refractory epilepsy. J Res Med Sci (2013) 0.75
Excess mortality and hospitalized morbidity in newly treated epilepsy patients. Neurology (2016) 0.75
Sudden unexpected death in epilepsy: experience from a tertiary epilepsy centre in Cyprus with review of the literature. Hippokratia (2016) 0.75
Antiepileptic Drugs Impair Shortening of Isolated Cardiomyocytes. Front Neurol (2017) 0.75
SUDEP--to discuss or not discuss: that is the question. Lancet Neurol (2006) 0.75
Ranking the Leading Risk Factors for Sudden Unexpected Death in Epilepsy. Front Neurol (2017) 0.75
Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia. Br J Dermatol (2017) 0.75
Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia (2010) 18.28
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia (2009) 7.03
Drug-resistant epilepsy. N Engl J Med (2011) 3.82
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59
Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet (2009) 2.28
Minimally invasive microendoscopy-assisted transforaminal lumbar interbody fusion with instrumentation. J Neurosurg Spine (2005) 2.23
A randomized trial comparing treatments for varicose veins. N Engl J Med (2014) 2.20
Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia (2011) 2.04
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial. Lancet Neurol (2011) 1.95
Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension (2004) 1.92
Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia (2005) 1.79
Sudden unexpected death in epilepsy: a search for risk factors. Epilepsy Behav (2006) 1.79
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol (2012) 1.78
Observation or operation for patients with an asymptomatic inguinal hernia: a randomized clinical trial. Ann Surg (2006) 1.73
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Combined analysis of risk factors for SUDEP. Epilepsia (2011) 1.71
Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci (2011) 1.66
Predictors of pharmacoresistant epilepsy. Epilepsy Res (2007) 1.65
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med (2010) 1.65
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open (2011) 1.64
Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia (2004) 1.53
Is refractory epilepsy preventable? Epilepsia (2002) 1.52
The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study. Br J Gen Pract (2006) 1.47
The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord (2006) 1.46
Sudden unexpected death in epilepsy. Epilepsy Behav (2011) 1.45
Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ (2002) 1.37
A DSM-IV-referenced screening instrument for preschool children: the Early Childhood Inventory-4. J Am Acad Child Adolesc Psychiatry (2002) 1.23
Asthma prevalence and morbidity among rural Iowa schoolchildren. J Allergy Clin Immunol (2004) 1.23
Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia (2013) 1.22
The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents. Target Oncol (2009) 1.21
Definition of refractory epilepsy: defining the indefinable? Lancet Neurol (2009) 1.16
The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol (2006) 1.11
Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study. Psychiatr Serv (2009) 1.10
Cdc7 kinase - a new target for drug development. Eur J Cancer (2010) 1.09
Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia (2003) 1.08
The role of covariates in estimating treatment effects and risk in long-term clinical trials. Stat Med (2002) 1.08
A pragmatic randomised, controlled trial of intensive care follow up programmes in improving longer-term outcomes from critical illness. The PRACTICAL study. BMC Health Serv Res (2007) 1.07
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics. Curr Control Trials Cardiovasc Med (2002) 1.07
The Pim kinases: new targets for drug development. Curr Drug Targets (2011) 1.06
The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Pers Disord (2006) 1.06
A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: rationale for trial, method, and description of sample. J Pers Disord (2006) 1.04
Combination therapy in epilepsy: when and what to use. Drugs (2006) 1.04
Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome? BMC Pregnancy Childbirth (2012) 1.03
Refractory epilepsy: mechanisms and solutions. Expert Rev Neurother (2006) 1.03
Multidrug-resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts. Epilepsia (2009) 1.02
Are there socioeconomic differences in responses to a commonly used self report measure of chronic illness? Int J Epidemiol (2005) 1.02
Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia (2005) 1.00
Pharmacotherapy of epilepsy: newly approved and developmental agents. CNS Drugs (2011) 1.00
Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia (2005) 1.00
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias. Blood (2010) 0.98
A prospective audit of adjunctive zonisamide in an everyday clinical setting. Epilepsy Behav (2010) 0.97
Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology (2003) 0.96
Cognitive therapy v. usual treatment for borderline personality disorder: prospective 6-year follow-up. Br J Psychiatry (2010) 0.95
Exploring change processes in compassion focused therapy in psychosis: results of a feasibility randomized controlled trial. Br J Clin Psychol (2012) 0.94
Recruitment to publicly funded trials--are surgical trials really different? Contemp Clin Trials (2008) 0.94
The impact of reduction mammaplasty on breast sensation: an analysis of multiple surgical techniques. Ann Plast Surg (2012) 0.93
Drug treatment of epilepsy: when does it fail and how to optimize its use? CNS Spectr (2004) 0.92
Microfluidic devices fabricated in poly(methyl methacrylate) using hot-embossing with integrated sampling capillary and fiber optics for fluorescence detection. Lab Chip (2002) 0.92
Thoracic microendoscopic discectomy: a human cadaver study. Spine (Phila Pa 1976) (2005) 0.92
Refractory epilepsy: a progressive, intractable but preventable condition? Seizure (2002) 0.91
A mobile phone intervention to reduce binge drinking among disadvantaged men: study protocol for a randomised controlled cost-effectiveness trial. Trials (2014) 0.91
Mortality in epilepsy. Epilepsy Behav (2007) 0.90
Antiepileptic drug monotherapy versus polytherapy: pursuing seizure freedom and tolerability in adults. Curr Opin Neurol (2012) 0.90
Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. Am J Cardiol (2012) 0.90
A novel dietary intervention to optimize vitamin E intake of pregnant women to 15 mg/day. J Acad Nutr Diet (2012) 0.90
Pharmacological outcomes in newly diagnosed epilepsy. Epilepsy Behav (2005) 0.90
Selection of antiepileptic drugs in adults. Neurol Clin (2009) 0.90
Levetiracetam monotherapy--outcomes from an epilepsy clinic. Seizure (2011) 0.90
Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia (2007) 0.89
Big data: the next Google. Interview by Duncan Graham-Rowe. Nature (2008) 0.89
Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing. Clin Neuropharmacol (2009) 0.89
Seizure freedom with more than one antiepileptic drug. Seizure (2002) 0.88
Outcomes in newly diagnosed localization-related epilepsies. Seizure (2005) 0.88
WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms. Eur J Oncol Nurs (2008) 0.87
The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J (2006) 0.87
Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav (2006) 0.87
Targeting sarcomas: novel biological agents and future perspectives. Curr Drug Targets (2009) 0.86
Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies. Epilepsy Res (2012) 0.86
IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy Childbirth (2006) 0.86
Large granular lymphocyte leukemia: natural history and response to treatment. Leuk Lymphoma (2010) 0.85
Levetiracetam in refractory epilepsy: a prospective observational study. Seizure (2005) 0.85